Hugo_Symbol	Entrez_Gene_Id	Center	NCBI_Build	Chromosome	Start_position	End_position	Strand	Variant_Classification	Variant_Type	Reference_Allele	Tumor_Seq_Allele1	Tumor_Seq_Allele2	dbSNP_RS	dbSNP_Val_Status	Tumor_Sample_Barcode	Matched_Norm_Sample_Barcode	Match_Norm_Seq_Allele1	Match_Norm_Seq_Allele2	Tumor_Validation_Allele1	Tumor_Validation_Allele2	Match_Norm_Validation_Allele1	Match_Norm_Validation_Allele2	Verification_Status	Validation_Status	Mutation_Status	Sequencing_Phase	Sequence_Source	Validation_Method	Score	BAM_file	Sequencer	Tumor_Sample_UUID	Matched_Norm_Sample_UUID	Genome_Change	Annotation_Transcript	Transcript_Strand	Transcript_Exon	Transcript_Position	cDNA_Change	Codon_Change	Protein_Change	Other_Transcripts	Refseq_mRNA_Id	Refseq_prot_Id	SwissProt_acc_Id	SwissProt_entry_Id	Description	UniProt_AApos	UniProt_Region	UniProt_Site	UniProt_Natural_Variations	UniProt_Experimental_Info	GO_Biological_Process	GO_Cellular_Component	GO_Molecular_Function	COSMIC_overlapping_mutations	COSMIC_fusion_genes	COSMIC_tissue_types_affected	COSMIC_total_alterations_in_gene	Tumorscape_Amplification_Peaks	Tumorscape_Deletion_Peaks	TCGAscape_Amplification_Peaks	TCGAscape_Deletion_Peaks	DrugBank	ref_context	gc_content	CCLE_ONCOMAP_overlapping_mutations	CCLE_ONCOMAP_total_mutations_in_gene	CGC_Mutation_Type	CGC_Translocation_Partner	CGC_Tumor_Types_Somatic	CGC_Tumor_Types_Germline	CGC_Other_Diseases	DNARepairGenes_Role	FamilialCancerDatabase_Syndromes	MUTSIG_Published_Results	OREGANNO_ID	OREGANNO_Values	i_1000Genome_AA	i_1000Genome_AC	i_1000Genome_AF	i_1000Genome_AFR_AF	i_1000Genome_AMR_AF	i_1000Genome_AN	i_1000Genome_ASN_AF	i_1000Genome_AVGPOST	i_1000Genome_CIEND	i_1000Genome_CIPOS	i_1000Genome_END	i_1000Genome_ERATE	i_1000Genome_EUR_AF	i_1000Genome_HOMLEN	i_1000Genome_HOMSEQ	i_1000Genome_LDAF	i_1000Genome_RSQ	i_1000Genome_SNPSOURCE	i_1000Genome_SVLEN	i_1000Genome_SVTYPE	i_1000Genome_THETA	i_1000Genome_VT	i_ACHILLES_Lineage_Results_Top_Genes	i_CGC_Cancer_Germline_Mut	i_CGC_Cancer_Molecular_Genetics	i_CGC_Cancer_Somatic_Mut	i_CGC_Cancer_Syndrome	i_CGC_Chr	i_CGC_Chr_Band	i_CGC_GeneID	i_CGC_Name	i_CGC_Other_Germline_Mut	i_CGC_Tissue_Type	i_COSMIC_n_overlapping_mutations	i_COSMIC_overlapping_mutation_descriptions	i_COSMIC_overlapping_primary_sites	i_ClinVar_ASSEMBLY	i_ClinVar_HGMD_ID	i_ClinVar_SYM	i_ClinVar_TYPE	i_ClinVar_rs	i_ESP_AA	i_ESP_AAC	i_ESP_AA_AC	i_ESP_AA_AGE	i_ESP_AA_GTC	i_ESP_AvgAAsampleReadDepth	i_ESP_AvgEAsampleReadDepth	i_ESP_AvgSampleReadDepth	i_ESP_CA	i_ESP_CDP	i_ESP_CG	i_ESP_CP	i_ESP_Chromosome	i_ESP_DBSNP	i_ESP_DP	i_ESP_EA_AC	i_ESP_EA_AGE	i_ESP_EA_GTC	i_ESP_EXOME_CHIP	i_ESP_FG	i_ESP_GL	i_ESP_GM	i_ESP_GS	i_ESP_GTC	i_ESP_GTS	i_ESP_GWAS_PUBMED	i_ESP_MAF	i_ESP_PH	i_ESP_PP	i_ESP_Position	i_ESP_TAC	i_ESP_TotalAAsamplesCovered	i_ESP_TotalEAsamplesCovered	i_ESP_TotalSamplesCovered	i_Ensembl_so_accession	i_Ensembl_so_term	i_Familial_Cancer_Genes_Reference	i_Familial_Cancer_Genes_Synonym	i_HGNC_Ensembl_Gene_ID	i_HGNC_HGNC_ID	i_HGNC_RefSeq_IDs	i_HGNC_Status	i_HGNC_UCSC_ID_supplied_by_UCSC_	i_HGVS_coding_DNA_change	i_HGVS_genomic_change	i_HGVS_protein_change	i_ORegAnno_bin	i_UniProt_alt_uniprot_accessions	i_annotation_transcript	i_build	i_ccds_id	i_dbNSFP_1000Gp1_AC	i_dbNSFP_1000Gp1_AF	i_dbNSFP_1000Gp1_AFR_AC	i_dbNSFP_1000Gp1_AFR_AF	i_dbNSFP_1000Gp1_AMR_AC	i_dbNSFP_1000Gp1_AMR_AF	i_dbNSFP_1000Gp1_ASN_AC	i_dbNSFP_1000Gp1_ASN_AF	i_dbNSFP_1000Gp1_EUR_AC	i_dbNSFP_1000Gp1_EUR_AF	i_dbNSFP_Ancestral_allele	i_dbNSFP_CADD_phred	i_dbNSFP_CADD_raw	i_dbNSFP_CADD_raw_rankscore	i_dbNSFP_ESP6500_AA_AF	i_dbNSFP_ESP6500_EA_AF	i_dbNSFP_Ensembl_geneid	i_dbNSFP_Ensembl_transcriptid	i_dbNSFP_FATHMM_pred	i_dbNSFP_FATHMM_rankscore	i_dbNSFP_FATHMM_score	i_dbNSFP_GERPplusplus_NR	i_dbNSFP_GERPplusplus_RS	i_dbNSFP_GERPplusplus_RS_rankscore	i_dbNSFP_Interpro_domain	i_dbNSFP_LRT_Omega	i_dbNSFP_LRT_converted_rankscore	i_dbNSFP_LRT_pred	i_dbNSFP_LRT_score	i_dbNSFP_LR_pred	i_dbNSFP_LR_rankscore	i_dbNSFP_LR_score	i_dbNSFP_MutationAssessor_pred	i_dbNSFP_MutationAssessor_rankscore	i_dbNSFP_MutationAssessor_score	i_dbNSFP_MutationTaster_converted_rankscore	i_dbNSFP_MutationTaster_pred	i_dbNSFP_MutationTaster_score	i_dbNSFP_Polyphen2_HDIV_pred	i_dbNSFP_Polyphen2_HDIV_rankscore	i_dbNSFP_Polyphen2_HDIV_score	i_dbNSFP_Polyphen2_HVAR_pred	i_dbNSFP_Polyphen2_HVAR_rankscore	i_dbNSFP_Polyphen2_HVAR_score	i_dbNSFP_RadialSVM_pred	i_dbNSFP_RadialSVM_rankscore	i_dbNSFP_RadialSVM_score	i_dbNSFP_Reliability_index	i_dbNSFP_SIFT_converted_rankscore	i_dbNSFP_SIFT_pred	i_dbNSFP_SIFT_score	i_dbNSFP_SLR_test_statistic	i_dbNSFP_SiPhy_29way_logOdds	i_dbNSFP_SiPhy_29way_logOdds_rankscore	i_dbNSFP_SiPhy_29way_pi	i_dbNSFP_UniSNP_ids	i_dbNSFP_Uniprot_aapos	i_dbNSFP_Uniprot_acc	i_dbNSFP_Uniprot_id	i_dbNSFP_aaalt	i_dbNSFP_aapos	i_dbNSFP_aapos_FATHMM	i_dbNSFP_aapos_SIFT	i_dbNSFP_aaref	i_dbNSFP_cds_strand	i_dbNSFP_codonpos	i_dbNSFP_fold_degenerate	i_dbNSFP_genename	i_dbNSFP_hg18_pos_1_coor_	i_dbNSFP_phastCons100way_vertebrate	i_dbNSFP_phastCons100way_vertebrate_rankscore	i_dbNSFP_phastCons46way_placental	i_dbNSFP_phastCons46way_placental_rankscore	i_dbNSFP_phastCons46way_primate	i_dbNSFP_phastCons46way_primate_rankscore	i_dbNSFP_phyloP100way_vertebrate	i_dbNSFP_phyloP100way_vertebrate_rankscore	i_dbNSFP_phyloP46way_placental	i_dbNSFP_phyloP46way_placental_rankscore	i_dbNSFP_phyloP46way_primate	i_dbNSFP_phyloP46way_primate_rankscore	i_dbNSFP_refcodon	i_gencode_transcript_name	i_gencode_transcript_status	i_gencode_transcript_tags	i_gencode_transcript_type	i_gene_id	i_gene_type	i_havana_transcript	i_init_t_lod	i_judgement	i_secondary_variant_classification	i_strand	i_t_lod_fstar	i_tumor_f	t_alt_count	t_ref_count	validation_alt_allele	validation_method	validation_status	validation_tumor_sample	i_picard_oxoQ	i_t_ALT_F1R2	i_t_ALT_F2R1	i_t_REF_F1R2	i_t_REF_F2R1	i_t_Foxog	pox	qox	pox_cutoff	isArtifactMode	oxoGCut	i_ffpe_Q	i_ffpe_F	i_ffpe_mode	i_ffpe_p_value	i_ffpe_q_value	i_ffpe_p_value_cutoff	i_ffpe_cut	pon_total_counts_coverage_less_8	pon_total_counts_coverage_greater_8	pon_alt_count_greater1_af_greater_01percent	pon_alt_count_greater2_af_greater_03percent	pon_alt_count_greater3_af_greater_1percent	pon_alt_count_greater3_af_greater_3percent	pon_alt_count_greater3_af_greater_20percent	pon_alt_count_greater10_af_greater_20percent	tumor_only_pon_weight	tumor_only_pass_weight	tumor_only_pass	pon_loglike	pon_weight	pon_pass_grid	pon_pass_loglike	pon_pass_weight	pon_coding	pon_low_alt_count	read_depth	Cosmic(v75) Counts
MTOR	2475	broad.mit.edu	37	1	11269464	11269464	+	Missense_Mutation	SNP	T	T	G			AC-V06-Tumor-SM-9J45X	none								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	AC-V06-Tumor-SM-9J45X	none	g.chr1:11269464T>G	ENST00000361445.4	-	25	3782	c.3706A>C	c.(3706-3708)Atg>Ctg	p.M1236L		NM_004958.3	NP_004949.1	P42345	MTOR_HUMAN	mechanistic target of rapamycin (serine/threonine kinase)	1236.0					cell growth|cellular response to hypoxia|insulin receptor signaling pathway|nerve growth factor receptor signaling pathway|peptidyl-serine phosphorylation|phosphatidylinositol-mediated signaling|protein autophosphorylation|protein catabolic process|response to amino acid stimulus|response to nutrient|T cell costimulation|TOR signaling cascade	endoplasmic reticulum membrane|Golgi membrane|lysosome|mitochondrial outer membrane|phosphatidylinositol 3-kinase complex|PML body|TORC1 complex|TORC2 complex	ATP binding|phosphoprotein binding|protein serine/threonine kinase activity			breast(5)|central_nervous_system(7)|endometrium(20)|kidney(34)|large_intestine(21)|lung(43)|ovary(9)|prostate(3)|skin(4)|upper_aerodigestive_tract(2)|urinary_tract(1)	149.0						CTCCTAAGCATCCGATGCTGG	0.468																																														0													263.0	249.0	254.0					1																	11269464.0		2203.0	4300.0	6503.0	SO:0001583	missense			ENSG00000198793	HGNC:3942	NM_004958	Approved	uc001asd.3	ENST00000361445.4:c.3706A>C	1.37:g.11269464T>G	ENSP00000354558:p.Met1236Leu		Q4LE76|Q5TER1|Q6LE87|Q96QG3|Q9Y4I3	ENST00000361445.4	37	CCDS127.1	.	.	.	.	.	.	.	.	.	.	T	12.73	2.025306	0.35701	.	.	ENSG00000198793	ENST00000361445;ENST00000539766	T	0.06218	3.33	5.78	5.78	0.91487	Armadillo-type fold (1);	0.101198	0.64402	D	0.000002	T	0.03477	0.0100	N	0.08118	0	0.80722	D	1	B	0.02656	0.0	B	0.04013	0.001	T	0.50833	-0.8781	10	0.27082	T	0.32	.	8.4795	0.33034	0.0:0.1446:0.0:0.8554	.	1236	P42345	MTOR_HUMAN	L	1236	ENSP00000354558:M1236L	ENSP00000354558:M1236L	M	-	1	0	MTOR	11192051	0.999000	0.42202	1.000000	0.80357	0.992000	0.81027	3.106000	0.50322	2.207000	0.71202	0.459000	0.35465	ATG	MTOR-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000005558.1	192.420368	KEEP		-	193.63221	0.407407	66	96					42.25	37	44	70	48	0.45679	0.0	0.0	1	0	0	31.39		0	0.0	0.0	0.870114	0	43	8245	18	22	5	0	0	0	4.671779e-05	0.003	1	-20.0	1.0	1	1	1	1	0	162	0.0
EP300	2033	broad.mit.edu	37	22	41574121	41574121	+	Missense_Mutation	SNP	A	A	G			AC-V07-Tumor-SM-9J45Y	none								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	AC-V07-Tumor-SM-9J45Y	none	g.chr22:41574121A>G	ENST00000263253.7	+	31	7625	c.6406A>G	c.(6406-6408)Atg>Gtg	p.M2136V	RP1-85F18.5_ENST00000420537.1_RNA|RP1-85F18.6_ENST00000415054.1_RNA	NM_001429.3	NP_001420.2	Q09472	EP300_HUMAN	E1A binding protein p300	2136.0	Interaction with HTLV-1 Tax.|Interaction with NCOA2.				apoptosis|cell cycle|DNA damage response, signal transduction by p53 class mediator resulting in induction of apoptosis|histone H4 acetylation|interspecies interaction between organisms|N-terminal peptidyl-lysine acetylation|positive regulation of sequence-specific DNA binding transcription factor activity|positive regulation of transcription from RNA polymerase II promoter|regulation of androgen receptor signaling pathway|response to estrogen stimulus|response to hypoxia	centrosome|histone acetyltransferase complex	androgen receptor binding|beta-catenin binding|DNA binding|histone acetyltransferase activity|RNA polymerase II activating transcription factor binding|transcription coactivator activity|zinc ion binding			NS(2)|breast(11)|central_nervous_system(7)|cervix(1)|endometrium(10)|haematopoietic_and_lymphoid_tissue(31)|kidney(5)|large_intestine(31)|liver(2)|lung(33)|ovary(2)|pancreas(4)|prostate(1)|skin(6)|stomach(1)|upper_aerodigestive_tract(8)|urinary_tract(16)	171.0						CATGAATCCAATGCAGGCGGG	0.642			"""T,  N, F, Mis, O"""	"""MLL, RUNXBP2"""	"""colorectal, breast, pancreatic, AML, ALL, DLBCL"""				Rubinstein-Taybi syndrome																												Rec	yes		22	22q13	2033.0	300 kd E1A-Binding protein gene		"""L, E"""	0													60.0	52.0	54.0					22																	41574121.0		2203.0	4300.0	6503.0	SO:0001583	missense	Familial Cancer Database	Broad Thumb-Hallux syndrome	ENSG00000100393	HGNC:3373	NM_001429	Approved	uc003azl.4	ENST00000263253.7:c.6406A>G	22.37:g.41574121A>G	ENSP00000263253:p.Met2136Val		B1AKC2	ENST00000263253.7	37	CCDS14010.1	.	.	.	.	.	.	.	.	.	.	A	3.302	-0.142708	0.06669	.	.	ENSG00000100393	ENST00000263253	D	0.83837	-1.77	4.93	3.88	0.44766	.	0.099386	0.42964	D	0.000628	T	0.78065	0.4225	L	0.55481	1.735	0.25011	N	0.991408	B	0.06786	0.001	B	0.06405	0.002	T	0.64609	-0.6367	10	0.33141	T	0.24	-3.328	11.9548	0.52974	0.8551:0.1449:0.0:0.0	.	2136	Q09472	EP300_HUMAN	V	2136	ENSP00000263253:M2136V	ENSP00000263253:M2136V	M	+	1	0	EP300	39904067	1.000000	0.71417	0.995000	0.50966	0.188000	0.23474	3.959000	0.56744	0.690000	0.31570	0.454000	0.30748	ATG	EP300-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000320600.1	50.177853	KEEP		+	50.45286	0.42	21	29					46.88	13	13	16	22	0.5	0.0	0.0	1	0	0	32.17		0	0.0	0.0	0.654019	0	61	8138	109	25	0	0	0	0	3.626565e-05	0.003	1	-20.0	1.0	1	1	1	1	0	50	0.0
EGFR	1956	broad.mit.edu	37	7	55229225	55229225	+	Missense_Mutation	SNP	C	C	A			AC-V08-Tumor-SM-9J45Z	none								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	AC-V08-Tumor-SM-9J45Z	none	g.chr7:55229225C>A	ENST00000275493.2	+	13	1709	c.1532C>A	c.(1531-1533)tCc>tAc	p.S511Y	EGFR_ENST00000455089.1_Missense_Mutation_p.S466Y|EGFR_ENST00000342916.3_Missense_Mutation_p.S511Y|EGFR_ENST00000344576.2_Missense_Mutation_p.S511Y|EGFR_ENST00000454757.2_Missense_Mutation_p.S458Y|EGFR_ENST00000442591.1_Missense_Mutation_p.S511Y	NM_005228.3	NP_005219.2	P00533	EGFR_HUMAN	epidermal growth factor receptor	511.0					activation of phospholipase A2 activity by calcium-mediated signaling|activation of phospholipase C activity|axon guidance|cell proliferation|cell-cell adhesion|negative regulation of apoptosis|negative regulation of epidermal growth factor receptor signaling pathway|ossification|positive regulation of catenin import into nucleus|positive regulation of cell migration|positive regulation of cyclin-dependent protein kinase activity involved in G1/S|positive regulation of epithelial cell proliferation|positive regulation of MAP kinase activity|positive regulation of nitric oxide biosynthetic process|positive regulation of phosphorylation|positive regulation of protein kinase B signaling cascade|protein autophosphorylation|protein insertion into membrane|regulation of nitric-oxide synthase activity|regulation of peptidyl-tyrosine phosphorylation|response to stress|response to UV-A	basolateral plasma membrane|endoplasmic reticulum membrane|endosome|extracellular space|Golgi membrane|integral to membrane|nuclear membrane|Shc-EGFR complex	actin filament binding|ATP binding|double-stranded DNA binding|epidermal growth factor receptor activity|identical protein binding|MAP/ERK kinase kinase activity|protein heterodimerization activity|protein phosphatase binding|receptor signaling protein tyrosine kinase activity			NS(2)|adrenal_gland(5)|biliary_tract(8)|bone(3)|breast(18)|central_nervous_system(106)|endometrium(26)|eye(3)|haematopoietic_and_lymphoid_tissue(9)|kidney(11)|large_intestine(85)|liver(2)|lung(13575)|oesophagus(21)|ovary(38)|pancreas(3)|peritoneum(11)|pleura(2)|prostate(35)|salivary_gland(11)|skin(9)|small_intestine(1)|soft_tissue(4)|stomach(41)|thymus(2)|thyroid(14)|upper_aerodigestive_tract(59)|urinary_tract(6)	14110.0	all_cancers(1;1.57e-46)|all_epithelial(1;5.62e-37)|Lung NSC(1;9.29e-25)|all_lung(1;4.39e-23)|Esophageal squamous(2;7.55e-08)|Breast(14;0.0318)		GBM - Glioblastoma multiforme(1;0)|all cancers(1;2.19e-314)|Lung(13;4.65e-05)|LUSC - Lung squamous cell carcinoma(13;0.000168)|STAD - Stomach adenocarcinoma(5;0.00164)|Epithelial(13;0.0607)		Cetuximab(DB00002)|Erlotinib(DB00530)|Gefitinib(DB00317)|Lapatinib(DB01259)|Lidocaine(DB00281)|Panitumumab(DB01269)|Trastuzumab(DB00072)	GCCTTGTGCTCCCCCGAGGGC	0.672		8.0	"""A, O, Mis"""		"""glioma, NSCLC"""	NSCLC			Lung Cancer, Familial Clustering of	TCGA GBM(3;<1E-08)|TSP Lung(4;<1E-08)																										yes	Dom	yes	Familial lung cancer	7	7p12.3-p12.1	1956.0	"""epidermal growth factor receptor (erythroblastic leukemia viral (v-erb-b) oncogene homolog, avian)"""		"""E, O"""	0								C	TYR/SER,TYR/SER,TYR/SER	0,4406		0,0,2203	77.0	80.0	79.0		1532,1532,1532	6.1	1.0	7		79.0	2,8598	2.2+/-6.3	0,2,4298	no	missense,missense,missense	EGFR	NM_005228.3,NM_201282.1,NM_201284.1	144,144,144	0,2,6501	AA,AC,CC		0.0233,0.0,0.0154	probably-damaging,probably-damaging,probably-damaging	511/1211,511/629,511/706	55229225.0	2,13004	2203.0	4300.0	6503.0	SO:0001583	missense	Familial Cancer Database	incl. Hereditary Lung cancer, Hereditary Non-Small Cell Lung cancer	ENSG00000146648	HGNC:3236	NM_005228	Approved	uc003tqk.3	ENST00000275493.2:c.1532C>A	7.37:g.55229225C>A	ENSP00000275493:p.Ser511Tyr		O00688|O00732|P06268|Q14225|Q68GS5|Q92795|Q9BZS2|Q9GZX1|Q9H2C9|Q9H3C9|Q9UMD7|Q9UMD8|Q9UMG5	ENST00000275493.2	37	CCDS5514.1	.	.	.	.	.	.	.	.	.	.	C	18.94	3.730442	0.69074	0.0	2.33E-4	ENSG00000146648	ENST00000455089;ENST00000342916;ENST00000395504;ENST00000344576;ENST00000275493;ENST00000442591;ENST00000454757;ENST00000533450	T;T;T;T;T;T	0.45668	0.89;0.89;0.89;0.89;0.89;0.89	6.07	6.07	0.98685	Growth factor, receptor (1);	0.175469	0.51477	D	0.000088	T	0.67163	0.2864	M	0.75150	2.29	0.53688	D	0.999978	D;D;D;D	0.89917	1.0;1.0;1.0;0.999	D;D;D;D	0.79108	0.992;0.981;0.987;0.959	T	0.67841	-0.5566	10	0.87932	D	0	.	19.2077	0.93739	0.0:1.0:0.0:0.0	.	466;511;511;511	Q504U8;P00533;P00533-3;P00533-4	.;EGFR_HUMAN;.;.	Y	466;511;381;511;511;511;458;305	ENSP00000415559:S466Y;ENSP00000342376:S511Y;ENSP00000345973:S511Y;ENSP00000275493:S511Y;ENSP00000410031:S511Y;ENSP00000395243:S458Y	ENSP00000275493:S511Y	S	+	2	0	EGFR	55196719	1.000000	0.71417	0.967000	0.41034	0.088000	0.18126	7.724000	0.84798	2.884000	0.98904	0.655000	0.94253	TCC	EGFR-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000251456.2	76.058881	KEEP		+	78.550991	0.329897	32	65					44.91	29	7	42	32	0.194444	1.82574e-34	1.977e-34	1	1	0	30.56	0.805556	0	0.0	0.0	0.054565	0	52	7875	264	120	14	8	0	0	0.0002595203	0.003	1	-5.994573	0.9967437	1	1	1	1	0	97	0.0
KMT2C	58508	broad.mit.edu	37	7	151927112	151927112	+	Splice_Site	SNP	C	C	G			AC-V08-Tumor-SM-9J45Z	none								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	AC-V08-Tumor-SM-9J45Z	none	g.chr7:151927112C>G	ENST00000355193.2	-	18	3090	c.2872G>C	c.(2872-2874)Gat>Cat	p.D958H	KMT2C_ENST00000262189.6_Splice_Site_p.D958H					lysine (K)-specific methyltransferase 2C																		ACACACATATCCTGAAGTTAA	0.353																																														0													50.0	42.0	45.0					7																	151927112.0		2194.0	4257.0	6451.0	SO:0001630	splice_region_variant			ENSG00000055609	HGNC:13726		Approved		ENST00000355193.2:c.2872-1G>C	7.37:g.151927112C>G				ENST00000355193.2	37		.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	C|C	16.79|16.79	3.219996|3.219996	0.58560|0.58560	.|.	.|.	ENSG00000055609|ENSG00000055609	ENST00000262189;ENST00000355193|ENST00000418673	D;D|.	0.87966|.	-2.32;-2.32|.	4.67|4.67	4.67|4.67	0.58626|0.58626	Zinc finger, PHD-finger (1);Zinc finger, RING/FYVE/PHD-type (1);Zinc finger, FYVE/PHD-type (1);|.	0.000000|.	0.42294|.	U|.	0.000737|.	T|T	0.72771|0.72771	0.3502|0.3502	M|M	0.63843|0.63843	1.955|1.955	0.80722|0.80722	D|D	1|1	D;D|.	0.89917|.	1.0;1.0|.	D;D|.	0.91635|.	0.997;0.999|.	T|T	0.72394|0.72394	-0.4307|-0.4307	10|5	0.87932|.	D|.	0|.	.|.	17.9348|17.9348	0.89009|0.89009	0.0:1.0:0.0:0.0|0.0:1.0:0.0:0.0	.|.	958;19|.	Q8NEZ4;Q8NEZ4-2|.	MLL3_HUMAN;.|.	H|A	958|113	ENSP00000262189:D958H;ENSP00000347325:D958H|.	ENSP00000262189:D958H|.	D|G	-|-	1|2	0|0	MLL3|MLL3	151558045|151558045	1.000000|1.000000	0.71417|0.71417	1.000000|1.000000	0.80357|0.80357	0.890000|0.890000	0.51754|0.51754	7.770000|7.770000	0.85390|0.85390	2.303000|2.303000	0.77524|0.77524	0.460000|0.460000	0.39030|0.39030	GAT|GGA	KMT2C-201	KNOWN	basic|appris_candidate_longest	protein_coding		protein_coding		-16.468943	KEEP	Missense_Mutation	-	23.65663	0.064039	13	190					44.91	15	10	141	164	0.4	0.0	0.0	1	0	0	30.56	0.6	0	0.0	0.0	0.076483	0	44	8187	8	4	23	68	0	0	0.0006624881	0.003	1	-2.08941	0.2338593	1	0	0	1	0	203	0.0
KMT2C	58508	broad.mit.edu	37	7	151927112	151927112	+	Splice_Site	SNP	C	C	G			AC-V08-Tumor-SM-9J461	none								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	AC-V08-Tumor-SM-9J461	none	g.chr7:151927112C>G	ENST00000355193.2	-	18	3090	c.2872G>C	c.(2872-2874)Gat>Cat	p.D958H	KMT2C_ENST00000262189.6_Splice_Site_p.D958H					lysine (K)-specific methyltransferase 2C																		ACACACATATCCTGAAGTTAA	0.353																																														0													50.0	42.0	45.0					7																	151927112.0		2194.0	4257.0	6451.0	SO:0001630	splice_region_variant			ENSG00000055609	HGNC:13726		Approved		ENST00000355193.2:c.2872-1G>C	7.37:g.151927112C>G				ENST00000355193.2	37		.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	C|C	16.79|16.79	3.219996|3.219996	0.58560|0.58560	.|.	.|.	ENSG00000055609|ENSG00000055609	ENST00000262189;ENST00000355193|ENST00000418673	D;D|.	0.87966|.	-2.32;-2.32|.	4.67|4.67	4.67|4.67	0.58626|0.58626	Zinc finger, PHD-finger (1);Zinc finger, RING/FYVE/PHD-type (1);Zinc finger, FYVE/PHD-type (1);|.	0.000000|.	0.42294|.	U|.	0.000737|.	T|T	0.72771|0.72771	0.3502|0.3502	M|M	0.63843|0.63843	1.955|1.955	0.80722|0.80722	D|D	1|1	D;D|.	0.89917|.	1.0;1.0|.	D;D|.	0.91635|.	0.997;0.999|.	T|T	0.72394|0.72394	-0.4307|-0.4307	10|5	0.87932|.	D|.	0|.	.|.	17.9348|17.9348	0.89009|0.89009	0.0:1.0:0.0:0.0|0.0:1.0:0.0:0.0	.|.	958;19|.	Q8NEZ4;Q8NEZ4-2|.	MLL3_HUMAN;.|.	H|A	958|113	ENSP00000262189:D958H;ENSP00000347325:D958H|.	ENSP00000262189:D958H|.	D|G	-|-	1|2	0|0	MLL3|MLL3	151558045|151558045	1.000000|1.000000	0.71417|0.71417	1.000000|1.000000	0.80357|0.80357	0.890000|0.890000	0.51754|0.51754	7.770000|7.770000	0.85390|0.85390	2.303000|2.303000	0.77524|0.77524	0.460000|0.460000	0.39030|0.39030	GAT|GGA	KMT2C-201	KNOWN	basic|appris_candidate_longest	protein_coding		protein_coding		4.80353	KEEP	Missense_Mutation	-	35.058091	0.106599	21	176					42.94	12	17	121	138	0.586207	0.0	0.0	1	0	0	30.18	0.413793	0	0.0	0.0	0.108266	0	44	8187	8	4	23	68	0	0	0.0006676009	0.003	1	-2.088474	0.4263269	1	0	0	1	0	197	0.0
KMT2C	58508	broad.mit.edu	37	7	151970864	151970864	+	Missense_Mutation	SNP	C	C	T	rs145606429	byFrequency	AC-V08-Tumor-SM-9J461	none								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	AC-V08-Tumor-SM-9J461	none	g.chr7:151970864C>T	ENST00000355193.2	-	7	1156	c.938G>A	c.(937-939)gGa>gAa	p.G313E	KMT2C_ENST00000262189.6_Missense_Mutation_p.G313E					lysine (K)-specific methyltransferase 2C																		GGTGCCGGCTCCTGCAGCACA	0.438																																														0													243.0	227.0	232.0					7																	151970864.0		2203.0	4300.0	6503.0	SO:0001583	missense			ENSG00000055609	HGNC:13726		Approved		ENST00000355193.2:c.938G>A	7.37:g.151970864C>T	ENSP00000347325:p.Gly313Glu			ENST00000355193.2	37		.	.	.	.	.	.	.	.	.	.	C	16.36	3.102547	0.56183	.	.	ENSG00000055609	ENST00000262189;ENST00000355193	T;T	0.68765	-0.35;-0.35	4.87	4.87	0.63330	Zinc finger, PHD-type (1);	0.000000	0.43747	D	0.000535	T	0.65354	0.2683	N	0.04116	-0.275	0.80722	D	1	D	0.89917	1.0	D	0.97110	1.0	T	0.70784	-0.4778	10	0.32370	T	0.25	.	18.3752	0.90433	0.0:1.0:0.0:0.0	.	313	Q8NEZ4	MLL3_HUMAN	E	313	ENSP00000262189:G313E;ENSP00000347325:G313E	ENSP00000262189:G313E	G	-	2	0	MLL3	151601797	1.000000	0.71417	0.850000	0.33497	0.967000	0.64934	5.353000	0.66034	2.423000	0.82170	0.650000	0.86243	GGA	KMT2C-201	KNOWN	basic|appris_candidate_longest	protein_coding		protein_coding		-65.510089	KEEP		-	34.318694	0.051282	24	444					42.94	13	19	242	374	0.59375	0.0	0.0	1	0	0	30.18	0.40625	1	5.77227e-19	9.05586e-19	0.134883	0	42	8166	0	16	47	62	0	0	0.0007913702	0.003	1	-2.128953	0.1494693	1	0	0	1	0	468	0.0
EGFR	1956	broad.mit.edu	37	7	55238013	55238013	+	Missense_Mutation	SNP	A	A	G			AC-V33-Tumor-SM-9J46Z	none								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	AC-V33-Tumor-SM-9J46Z	none	g.chr7:55238013A>G	ENST00000344576.2	+	16	2139	c.1894A>G	c.(1894-1896)Agt>Ggt	p.S632G	EGFR_ENST00000455089.1_Intron|EGFR_ENST00000442591.1_Intron|EGFR_ENST00000454757.2_Intron|EGFR_ENST00000275493.2_Intron	NM_201284.1	NP_958441.1	P00533	EGFR_HUMAN	epidermal growth factor receptor	0.0					activation of phospholipase A2 activity by calcium-mediated signaling|activation of phospholipase C activity|axon guidance|cell proliferation|cell-cell adhesion|negative regulation of apoptosis|negative regulation of epidermal growth factor receptor signaling pathway|ossification|positive regulation of catenin import into nucleus|positive regulation of cell migration|positive regulation of cyclin-dependent protein kinase activity involved in G1/S|positive regulation of epithelial cell proliferation|positive regulation of MAP kinase activity|positive regulation of nitric oxide biosynthetic process|positive regulation of phosphorylation|positive regulation of protein kinase B signaling cascade|protein autophosphorylation|protein insertion into membrane|regulation of nitric-oxide synthase activity|regulation of peptidyl-tyrosine phosphorylation|response to stress|response to UV-A	basolateral plasma membrane|endoplasmic reticulum membrane|endosome|extracellular space|Golgi membrane|integral to membrane|nuclear membrane|Shc-EGFR complex	actin filament binding|ATP binding|double-stranded DNA binding|epidermal growth factor receptor activity|identical protein binding|MAP/ERK kinase kinase activity|protein heterodimerization activity|protein phosphatase binding|receptor signaling protein tyrosine kinase activity			NS(2)|adrenal_gland(5)|biliary_tract(8)|bone(3)|breast(18)|central_nervous_system(106)|endometrium(26)|eye(3)|haematopoietic_and_lymphoid_tissue(9)|kidney(11)|large_intestine(85)|liver(2)|lung(13575)|oesophagus(21)|ovary(38)|pancreas(3)|peritoneum(11)|pleura(2)|prostate(35)|salivary_gland(11)|skin(9)|small_intestine(1)|soft_tissue(4)|stomach(41)|thymus(2)|thyroid(14)|upper_aerodigestive_tract(59)|urinary_tract(6)	14110.0	all_cancers(1;1.57e-46)|all_epithelial(1;5.62e-37)|Lung NSC(1;9.29e-25)|all_lung(1;4.39e-23)|Esophageal squamous(2;7.55e-08)|Breast(14;0.0318)		GBM - Glioblastoma multiforme(1;0)|all cancers(1;2.19e-314)|Lung(13;4.65e-05)|LUSC - Lung squamous cell carcinoma(13;0.000168)|STAD - Stomach adenocarcinoma(5;0.00164)|Epithelial(13;0.0607)		Cetuximab(DB00002)|Erlotinib(DB00530)|Gefitinib(DB00317)|Lapatinib(DB01259)|Lidocaine(DB00281)|Panitumumab(DB01269)|Trastuzumab(DB00072)	AGGAAATGAGAGTCTCAAAGC	0.463		8.0	"""A, O, Mis"""		"""glioma, NSCLC"""	NSCLC			Lung Cancer, Familial Clustering of	TCGA GBM(3;<1E-08)|TSP Lung(4;<1E-08)																										yes	Dom	yes	Familial lung cancer	7.0	7p12.3-p12.1	1956.0	"""epidermal growth factor receptor (erythroblastic leukemia viral (v-erb-b) oncogene homolog, avian)"""		"""E, O"""	0													94.0	79.0	84.0					7																	55238013.0		2203.0	4300.0	6503.0	SO:0001583	missense	Familial Cancer Database	incl. Hereditary Lung cancer, Hereditary Non-Small Cell Lung cancer	ENSG00000146648	HGNC:3236	NM_005228	Approved	uc003tqk.3	ENST00000344576.2:c.1894A>G	7.37:g.55238013A>G	ENSP00000345973:p.Ser632Gly		O00688|O00732|P06268|Q14225|Q68GS5|Q92795|Q9BZS2|Q9GZX1|Q9H2C9|Q9H3C9|Q9UMD7|Q9UMD8|Q9UMG5	ENST00000344576.2	37	CCDS5515.1	.	.	.	.	.	.	.	.	.	.	A	2.154	-0.393804	0.04899	.	.	ENSG00000146648	ENST00000344576	T	0.79749	-1.3	2.43	-1.9	0.07665	.	.	.	.	.	T	0.51584	0.1683	N	0.11560	0.145	0.09310	N	1	B	0.06786	0.001	B	0.04013	0.001	T	0.44314	-0.9336	9	0.02654	T	1	.	2.2558	0.04054	0.4767:0.0:0.2955:0.2278	.	632	P00533-3	.	G	632	ENSP00000345973:S632G	ENSP00000345973:S632G	S	+	1	0	EGFR	55205507	0.000000	0.05858	0.000000	0.03702	0.007000	0.05969	-0.507000	0.06352	-0.411000	0.07530	0.460000	0.39030	AGT	EGFR-002	KNOWN	basic|CCDS	protein_coding		protein_coding	OTTHUMT00000251457.1	302.963733	KEEP		+	304.178005	0.589595	102	71					80.62	71	48	46	44	0.403361	0.0	0.0	1	0	0	30.23		0	0.0	0.0	0.139131	0	47	8144	103	34	5	0	0	0	7.873681e-05	0.003	1	-20.0	1.0	1	1	1	1	0	173	0.0
KMT2C	58508	broad.mit.edu	37	7	151927103	151927103	+	Missense_Mutation	SNP	C	C	T			AC-V34-Tumor-SM-9J471	none								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	AC-V34-Tumor-SM-9J471	none	g.chr7:151927103C>T	ENST00000355193.2	-	18	3099	c.2881G>A	c.(2881-2883)Gta>Ata	p.V961I	KMT2C_ENST00000262189.6_Missense_Mutation_p.V961I					lysine (K)-specific methyltransferase 2C																		CCACAAACTACACACATATCC	0.343																																														0													62.0	51.0	55.0					7																	151927103.0		2200.0	4278.0	6478.0	SO:0001583	missense			ENSG00000055609	HGNC:13726		Approved		ENST00000355193.2:c.2881G>A	7.37:g.151927103C>T	ENSP00000347325:p.Val961Ile			ENST00000355193.2	37		.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	C|C	19.99|19.99	3.928420|3.928420	0.73327|0.73327	.|.	.|.	ENSG00000055609|ENSG00000055609	ENST00000418673|ENST00000262189;ENST00000355193	D|D;D	0.94687|0.87491	-3.49|-2.26;-2.26	4.67|4.67	4.67|4.67	0.58626|0.58626	.|Zinc finger, PHD-finger (1);Zinc finger, RING/FYVE/PHD-type (1);Zinc finger, RING-type (1);Zinc finger, PHD-type (1);Zinc finger, FYVE/PHD-type (1);	.|0.000000	.|0.37053	.|U	.|0.002269	D|D	0.91334|0.91334	0.7267|0.7267	L|L	0.47716|0.47716	1.5|1.5	0.80722|0.80722	D|D	1|1	.|D;D	.|0.69078	.|0.997;0.997	.|D;D	.|0.79784	.|0.992;0.993	D|D	0.92395|0.92395	0.5924|0.5924	7|10	0.87932|0.72032	D|D	0|0.01	.|.	17.9348|17.9348	0.89009|0.89009	0.0:1.0:0.0:0.0|0.0:1.0:0.0:0.0	.|.	.|961;22	.|Q8NEZ4;Q8NEZ4-2	.|MLL3_HUMAN;.	Y|I	116|961	ENSP00000403483:C116Y|ENSP00000262189:V961I;ENSP00000347325:V961I	ENSP00000403483:C116Y|ENSP00000262189:V961I	C|V	-|-	2|1	0|0	MLL3|MLL3	151558036|151558036	1.000000|1.000000	0.71417|0.71417	1.000000|1.000000	0.80357|0.80357	0.964000|0.964000	0.63967|0.63967	7.770000|7.770000	0.85390|0.85390	2.303000|2.303000	0.77524|0.77524	0.460000|0.460000	0.39030|0.39030	TGT|GTA	KMT2C-201	KNOWN	basic|appris_candidate_longest	protein_coding		protein_coding		5.429247	KEEP		-	14.979617	0.135135	10	64					74.36	8	5	53	53	0.384615	0.0	0.0	1	0	0	31.55	0.615385	1	0.00010058	0.00011711	0.411799	0	43	8272	0	7	6	0	0	0	4.48972e-05	0.003	1	-7.974102	1.0	1	1	1	1	0	74	0.0
